Vidal-Petiot E - Search Results

1

Prevalence and factors associated with masked hypertension in chronic kidney disease.

Legrand F, Motiejunaite J, Arnoult F, Lahens A, Tabibzadeh N, Robert-Mercier T, Rouzet F, De Pinho NA, Vrtovsnik F, Flamant M, Vidal-Petiot E. Legrand F, et al. Among authors: vidal petiot e. J Hypertens. 2024 Jun 1;42(6):1000-1008. doi: 10.1097/HJH.0000000000003680. Epub 2024 Feb 9. J Hypertens. 2024. PMID: 38647162

2

Does exercise stress testing carry an incremental prognostic value beyond resting office blood pressure?

Motiejunaite J, Vidal-Petiot E. Motiejunaite J, et al. J Hypertens. 2022 Jan 1;40(1):24-26. doi: 10.1097/HJH.0000000000003016. J Hypertens. 2022. PMID: 34857701 No abstract available.

3

A case report of reninoma: radiological and pathological features of the tumour and characterization of tumour-derived juxtaglomerular cells in culture.

Vidal-Petiot E, Bens M, Choudat L, Fernandez P, Rouzet F, Hermieu JF, Bruneval P, Goujon JM, Flamant M, Vandewalle A. Vidal-Petiot E, et al. J Hypertens. 2015 Aug;33(8):1709-15. doi: 10.1097/HJH.0000000000000592. J Hypertens. 2015. PMID: 26132761

4

Estimation of populational 24-h urinary sodium and potassium excretion from spot urine samples: evaluation of four formulas in a large national representative population.

Vidal-Petiot E, Joseph A, Flamant M. Vidal-Petiot E, et al. J Hypertens. 2017 May;35(5):1119-1120. doi: 10.1097/HJH.0000000000001317. J Hypertens. 2017. PMID: 28353550 No abstract available.

5

External validation and comparison of formulae estimating 24-h sodium intake from a fasting morning urine sample.

Vidal-Petiot E, Joseph A, Resche-Rigon M, Boutten A, Mullaert J, d' Ortho MP, Vrtovsnik F, Steg PG, Flamant M. Vidal-Petiot E, et al. J Hypertens. 2018 Apr;36(4):785-792. doi: 10.1097/HJH.0000000000001609. J Hypertens. 2018. PMID: 29120960

6

Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study.

Vidal-Petiot E, Metzger M, Faucon AL, Boffa JJ, Haymann JP, Thervet E, Houillier P, Geri G, Stengel B, Vrtovsnik F, Flamant M; NephroTest study group. Vidal-Petiot E, et al. J Am Heart Assoc. 2018 Oct 2;7(19):e010278. doi: 10.1161/JAHA.118.010278. J Am Heart Assoc. 2018. PMID: 30371309 Free PMC article.

7

Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019: analysing in-hospital exposure generates a biased seemingly protective effect of treatment.

Lahens A, Mullaert J, Gressens S, Gault N, Flamant M, Deconinck L, Joly V, Yazdanpanah Y, Lescure FX, Vidal-Petiot E. Lahens A, et al. J Hypertens. 2021 Feb 1;39(2):367-375. doi: 10.1097/HJH.0000000000002658. J Hypertens. 2021. PMID: 33021511

8

In reply to 'external validation of the berlin initiative study equations'.

Vidal-Petiot E, Vrtovsnik F, Flamant M. Vidal-Petiot E, et al. Am J Kidney Dis. 2014 Oct;64(4):659. doi: 10.1053/j.ajkd.2014.07.008. Am J Kidney Dis. 2014. PMID: 25257329 No abstract available.

9

[Measurement and estimation of glomerular filtration rate].

Vidal-Petiot E, Flamant M. Vidal-Petiot E, et al. Nephrol Ther. 2017 Dec;13(7):560-568. doi: 10.1016/j.nephro.2017.10.001. Epub 2017 Nov 13. Nephrol Ther. 2017. PMID: 29146282 Review. French.

10

Risk of Ascending Aortic Aneurysm in Patients With Autosomal Dominant Polycystic Kidney Disease.

Bouleti C, Flamant M, Escoubet B, Arnoult F, Milleron O, Vidal-Petiot E, Langeois M, Ou P, Vrtovsnik F, Jondeau G. Bouleti C, et al. Am J Cardiol. 2019 Feb 1;123(3):482-488. doi: 10.1016/j.amjcard.2018.10.030. Epub 2018 Nov 6. Am J Cardiol. 2019. PMID: 30477801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page